These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 35964032)
1. Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases. Fan Y; Dong Y; Sun X; Wang H; Zhao P; Wang H; Jiang X BMC Cancer; 2022 Aug; 22(1):889. PubMed ID: 35964032 [TBL] [Abstract][Full Text] [Related]
2. Habitat-Based Radiomics for Predicting EGFR Mutations in Exon 19 and 21 From Brain Metastasis. Yang C; Fan Y; Zhao D; Wang Z; Wang X; Wang H; Hu Y; He L; Zhang J; Wang Y; Liu Y; Sha X; Su J Acad Radiol; 2024 Sep; 31(9):3764-3773. PubMed ID: 38599906 [TBL] [Abstract][Full Text] [Related]
3. Tumor-liver interface in MRI of liver metastasis enables prediction of EGFR mutation in patients with lung cancer: A proof-of-concept study. Hou S; Wang H; Wang X; Chen H; Zhou B; Meng R; Sha X; Chang S; Wang H; Jiang W Med Phys; 2024 Feb; 51(2):1083-1091. PubMed ID: 37408393 [TBL] [Abstract][Full Text] [Related]
4. Radiomics of Spinal Metastases Originating From Primary Nonsmall Cell Lung Cancer or Breast Cancer and Ability to Predict Epidermal Growth Factor Receptor Mutation/Ki-67 Levels. Niu S; Zhang H; Wang X; Jiang W J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):643-649. PubMed ID: 37380152 [TBL] [Abstract][Full Text] [Related]
5. MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma. Cao R; Dong Y; Wang X; Ren M; Wang X; Zhao N; Yu T; Zhang L; Luo Y; Cui EN; Jiang X Acad Radiol; 2022 Mar; 29(3):e9-e17. PubMed ID: 34332860 [TBL] [Abstract][Full Text] [Related]
6. Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma. Fan Y; Dong Y; Wang H; Wang H; Sun X; Wang X; Zhao P; Luo Y; Jiang X Eur Radiol; 2022 Oct; 32(10):6739-6751. PubMed ID: 35729427 [TBL] [Abstract][Full Text] [Related]
7. Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status. Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368 [TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma. Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577 [TBL] [Abstract][Full Text] [Related]
9. Radiomics for Detection of the EGFR Mutation in Liver Metastatic NSCLC. Hou S; Fan Y; Wang X; Su J; Ren M; Wu Y; Zhou J; Qu M; Luo Y; Jiang W Acad Radiol; 2023 Jun; 30(6):1039-1046. PubMed ID: 35907759 [TBL] [Abstract][Full Text] [Related]
10. Radiomics evaluates the EGFR mutation status from the brain metastasis: a multi-center study. Cao R; Pang Z; Wang X; Du Z; Chen H; Liu J; Yue Z; Wang H; Luo Y; Jiang X Phys Med Biol; 2022 Jun; 67(12):. PubMed ID: 35588722 [No Abstract] [Full Text] [Related]
11. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC. Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868 [TBL] [Abstract][Full Text] [Related]
12. Combined radiomics of primary tumour and bone metastasis improve the prediction of EGFR mutation status and response to EGFR-TKI therapy for NSCLC. Cheng Y; Wang H; Yuan W; Wang H; Zhu Y; Chen H; Jiang W Phys Med; 2023 Dec; 116():103177. PubMed ID: 38000098 [TBL] [Abstract][Full Text] [Related]
13. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases. Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362 [TBL] [Abstract][Full Text] [Related]
14. Radiomics signature of brain metastasis: prediction of EGFR mutation status. Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315 [TBL] [Abstract][Full Text] [Related]
15. Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis. Hu Y; Geng Y; Wang H; Chen H; Wang Z; Fu L; Huang B; Jiang W J Comput Assist Tomogr; 2024 Sep-Oct 01; 48(5):780-788. PubMed ID: 38498926 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of prediction of the EGFR mutation and subtypes based on the spinal metastasis from primary lung adenocarcinoma. Cao R; Chen H; Wang H; Wang Y; Cui EN; Jiang W Front Oncol; 2023; 13():1154327. PubMed ID: 37143947 [TBL] [Abstract][Full Text] [Related]
17. MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients. Ren M; Yang H; Lai Q; Shi D; Liu G; Shuang X; Su J; Xie L; Dong Y; Jiang X Med Phys; 2021 Sep; 48(9):5142-5151. PubMed ID: 34318502 [TBL] [Abstract][Full Text] [Related]
18. Preoperative MRI-Based Radiomics of Brain Metastasis to Assess T790M Resistance Mutation After EGFR-TKI Treatment in NSCLC. Fan Y; He L; Yang H; Wang Y; Su J; Hou S; Luo Y; Jiang X J Magn Reson Imaging; 2023 Jun; 57(6):1778-1787. PubMed ID: 36165534 [TBL] [Abstract][Full Text] [Related]
19. Detailed identification of epidermal growth factor receptor mutations in lung adenocarcinoma: Combining radiomics with machine learning. Li S; Luo T; Ding C; Huang Q; Guan Z; Zhang H Med Phys; 2020 Aug; 47(8):3458-3466. PubMed ID: 32416013 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases. Qi H; Hou Y; Zheng Z; Zheng M; Qiao Q; Wang Z; Sun X; Xing L BMC Cancer; 2024 Mar; 24(1):362. PubMed ID: 38515096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]